COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?

Objectives. Acute pulmonary embolism is a protentional fatal complication of COVID-19. The aim of this study is to investigate whether pulmonary embolism is due to thrombus migration from the venous circulation to the pulmonary arteries or due to local thrombus formation secondary to local inflammat...

Full description

Bibliographic Details
Main Authors: Rashid AL Umairi, Khadija AL Adawi, Maryam AL Khoori, Ahmed AL Lawati, Sachin Jose
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Radiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2023/3844069
_version_ 1797783600982130688
author Rashid AL Umairi
Khadija AL Adawi
Maryam AL Khoori
Ahmed AL Lawati
Sachin Jose
author_facet Rashid AL Umairi
Khadija AL Adawi
Maryam AL Khoori
Ahmed AL Lawati
Sachin Jose
author_sort Rashid AL Umairi
collection DOAJ
description Objectives. Acute pulmonary embolism is a protentional fatal complication of COVID-19. The aim of this study is to investigate whether pulmonary embolism is due to thrombus migration from the venous circulation to the pulmonary arteries or due to local thrombus formation secondary to local inflammation. This was determined by looking at the distribution of pulmonary embolism in relation to lung parenchymal changes in patients with COVID-19 pneumonia. Methods. Retrospectively, we identified pulmonary computed tomography angiography (CTPA) of patients admitted to the Royal Hospital between November 1st, 2020, and October 31, 2021, with a confirmed diagnosis of COVID-19. The CTPAs were examined for the presence of pulmonary embolism and the distribution of the pulmonary embolism in relation with lung parenchymal changes. Results. A total of 215 patients admitted with COVID-19 pneumonia had CTPA. Out of them, 64 patients had pulmonary embolisms (45 men and 19 women; mean age: 58.4 years with a range of 36–98 years). The prevalence of pulmonary embolism (PE) was 29.8% (64/215). Pulmonary embolism was more frequently seen in the lower lobes. 51 patients had PE within the diseased lung parenchyma and 13 patients had PE within normal lung parenchyma. Conclusion. The strong association between pulmonary artery embolism and lung parenchymal changes in patients admitted with COVID-19 pneumonia suggests local thrombus formation.
first_indexed 2024-03-13T00:28:12Z
format Article
id doaj.art-8d73666eb3114329b79cff7970f3ab8e
institution Directory Open Access Journal
issn 2090-195X
language English
last_indexed 2024-03-13T00:28:12Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Radiology Research and Practice
spelling doaj.art-8d73666eb3114329b79cff7970f3ab8e2023-07-11T00:00:00ZengHindawi LimitedRadiology Research and Practice2090-195X2023-01-01202310.1155/2023/3844069COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?Rashid AL Umairi0Khadija AL Adawi1Maryam AL Khoori2Ahmed AL Lawati3Sachin Jose4Radiology DepartmentRadiology DepartmentRadiology DepartmentRadiology DepartmentMedical Specialty BoardObjectives. Acute pulmonary embolism is a protentional fatal complication of COVID-19. The aim of this study is to investigate whether pulmonary embolism is due to thrombus migration from the venous circulation to the pulmonary arteries or due to local thrombus formation secondary to local inflammation. This was determined by looking at the distribution of pulmonary embolism in relation to lung parenchymal changes in patients with COVID-19 pneumonia. Methods. Retrospectively, we identified pulmonary computed tomography angiography (CTPA) of patients admitted to the Royal Hospital between November 1st, 2020, and October 31, 2021, with a confirmed diagnosis of COVID-19. The CTPAs were examined for the presence of pulmonary embolism and the distribution of the pulmonary embolism in relation with lung parenchymal changes. Results. A total of 215 patients admitted with COVID-19 pneumonia had CTPA. Out of them, 64 patients had pulmonary embolisms (45 men and 19 women; mean age: 58.4 years with a range of 36–98 years). The prevalence of pulmonary embolism (PE) was 29.8% (64/215). Pulmonary embolism was more frequently seen in the lower lobes. 51 patients had PE within the diseased lung parenchyma and 13 patients had PE within normal lung parenchyma. Conclusion. The strong association between pulmonary artery embolism and lung parenchymal changes in patients admitted with COVID-19 pneumonia suggests local thrombus formation.http://dx.doi.org/10.1155/2023/3844069
spellingShingle Rashid AL Umairi
Khadija AL Adawi
Maryam AL Khoori
Ahmed AL Lawati
Sachin Jose
COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
Radiology Research and Practice
title COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
title_full COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
title_fullStr COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
title_full_unstemmed COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
title_short COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?
title_sort covid 19 associated thrombotic complication is it pulmonary embolism or in situ thrombosis
url http://dx.doi.org/10.1155/2023/3844069
work_keys_str_mv AT rashidalumairi covid19associatedthromboticcomplicationisitpulmonaryembolismorinsituthrombosis
AT khadijaaladawi covid19associatedthromboticcomplicationisitpulmonaryembolismorinsituthrombosis
AT maryamalkhoori covid19associatedthromboticcomplicationisitpulmonaryembolismorinsituthrombosis
AT ahmedallawati covid19associatedthromboticcomplicationisitpulmonaryembolismorinsituthrombosis
AT sachinjose covid19associatedthromboticcomplicationisitpulmonaryembolismorinsituthrombosis